<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Foos G</submitter><funding>National Institute of Allergy and Infectious Diseases</funding><funding>NIAID NIH HHS</funding><funding>National Cancer Institute</funding><funding>NCI NIH HHS</funding><funding>National Institutes of Health</funding><pagination>578-589</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11017785</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>84(11)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>The Cancer Epitope Database and Analysis Resource (CEDAR) is a newly developed repository of cancer epitope data from peer-reviewed publications, which includes epitope-specific T cell, antibody, and MHC ligand assays. Here we focus on prostate cancer as our first cancer category to demonstrate the capabilities of CEDAR, and to shed light on the advances of epitope-related prostate cancer research.&lt;h4>Results&lt;/h4>The meta-analysis focused on a subset of data describing epitopes from 8 prostate-specific (PS) antigens. A total of 460 epitopes were associated with these proteins, 187 T cell, 109B cell, and 271 MHC ligand epitopes. The number of epitopes was not correlated with the length of the protein; however, we found a significant positive correlation between the number</pubmed_abstract><journal>Human immunology</journal><pubmed_title>A meta-analysis of epitopes in prostate-specific antigens identifies opportunities and knowledge gaps.</pubmed_title><pmcid>PMC11017785</pmcid><funding_grant_id>75N93019C00001</funding_grant_id><funding_grant_id>U24 CA248138</funding_grant_id><funding_grant_id>U24CA248138</funding_grant_id><pubmed_authors>Carter H</pubmed_authors><pubmed_authors>Kosaloglu-Yalcin Z</pubmed_authors><pubmed_authors>Peters B</pubmed_authors><pubmed_authors>Sette A</pubmed_authors><pubmed_authors>Foos G</pubmed_authors><pubmed_authors>Blazeska N</pubmed_authors><pubmed_authors>Nielsen M</pubmed_authors></additional><is_claimable>false</is_claimable><name>A meta-analysis of epitopes in prostate-specific antigens identifies opportunities and knowledge gaps.</name><description>&lt;h4>Background&lt;/h4>The Cancer Epitope Database and Analysis Resource (CEDAR) is a newly developed repository of cancer epitope data from peer-reviewed publications, which includes epitope-specific T cell, antibody, and MHC ligand assays. Here we focus on prostate cancer as our first cancer category to demonstrate the capabilities of CEDAR, and to shed light on the advances of epitope-related prostate cancer research.&lt;h4>Results&lt;/h4>The meta-analysis focused on a subset of data describing epitopes from 8 prostate-specific (PS) antigens. A total of 460 epitopes were associated with these proteins, 187 T cell, 109B cell, and 271 MHC ligand epitopes. The number of epitopes was not correlated with the length of the protein; however, we found a significant positive correlation between the number</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Nov</publication><modification>2026-06-02T03:59:47.056Z</modification><creation>2025-04-06T23:15:49.075Z</creation></dates><accession>S-EPMC11017785</accession><cross_references><pubmed>37679223</pubmed><doi>10.1016/j.humimm.2023.08.145</doi></cross_references></HashMap>